)
Avient (AVNT) investor relations material
Avient Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 sales rose 10.5% to $891.2M, with organic growth of 10.6%; adjusted EPS increased 23% to $0.86, above the $0.80 outlook.
Adjusted EBITDA margin reached a Q3 record 17.3%, up 80 bps YoY; both segments contributed to growth.
FY2026 adjusted EPS guidance increased, while low-end adjusted EBITDA and free cash flow guidance rose.
Financial highlights
Q3 adjusted EBITDA was $154.4M, up 16.2% as reported; adjusted EPS was $0.86 versus $0.70 a year earlier.
September YTD sales were $2,655.6M, up 4.2% organically and 6.2% as reported; adjusted EBITDA was $472.4M, up 8.1% organically.
September YTD adjusted EPS was $2.65, up 13.2% organically and 17.3% as reported; adjusted EBITDA margin expanded 70 bps to 17.8%.
Q3 GAAP operating income was $82.6M versus $67.1M; diluted EPS was $0.46 versus $0.36.
September YTD operating cash flow was $180.0M versus $133.8M.
Outlook and guidance
FY2026 adjusted EBITDA guidance is $593M–$603M, implying 9%–11% growth, revised from $575M–$603M; adjusted EPS guidance is $3.22–$3.32, revised from $3.10–$3.25.
FY2026 free cash flow guidance is $215M–$230M, up from $210M–$230M; revenue growth outlook is mid- to high-single digits as reported.
FY2026 capital expenditure outlook is ~$120M, directed toward growth-vector investments.
Year-end 2026 net leverage is expected at 2.2x–2.3x, versus 2.6x at year-end 2025.
Guidance balances improving consumer and infrastructure spending and faster EU and US defense spending against inflation, higher rates, and global demand uncertainty.
- FY06 earnings rebounded, but 2007 margin gains faced soft demand and chlorovinyl headwinds.AVNT
Q4 2006 - Debt fell after the OxyVinyls sale, but weak construction and remediation charges depressed 2007 earnings.AVNT
Q4 2007 - Late-year demand collapse and large one-time charges turned modest sales growth into a $272.9M loss.AVNT
Q4 2008 - Operating income recovered to $98.4M as cash strengthened despite a 24.8% sales decline.AVNT
Q4 2009 - Volume recovery and efficiency lifted FY2010 results, while tax and one-time gains boosted net income.AVNT
Q4 2010 - FY11 growth met a pension-driven Q4 operating loss and major portfolio changes.AVNT
Q4 2011 - Record adjusted EPS and a specialty-led mix shift offset soft markets and lower reported earnings.AVNT
Q4 2012 - Acquisitions drove FY13 growth, alongside a major divestiture gain and integration costs.AVNT
Q4 2013 - Record adjusted EPS and stronger specialty mix offset restructuring and pension charges.AVNT
Q4 2014 - Adjusted EPS rose 9%, as specialty growth offset revenue and DSS headwinds.AVNT
Q4 2015
)
)
)
)
)
)
)
)